Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: The University of Michigan experience

Breast Journal

Volumn 13, Issue 4, 2007, Pages 392-400

  Ben David, Merav A ^a   Sturtz, David E ^a   Griffith, Kent A ^a   Douglas, Kathye R ^a   Hayman, James A ^a   Lichter, Allen S ^a   Pierce, Lori J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Breast conservation; DCIS; Lung density correction; Radiotherapy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CARCINOMA; BREAST SURGERY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; FAMILY HISTORY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; SCORING SYSTEM; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; ESTHETICS; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PATIENT SATISFACTION; RADIATION DOSAGE; RADIATION INJURIES; RADIATION ONCOLOGY; SKIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34250822214     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00447.x     Document Type: Article

References (41)

1. Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med 2004 350: 1430 41.
2. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993 328: 1581 86.
3. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998 16: 441 52.
4. Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000 355: 528 33.
5. Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003 362: 95 102.
6. Fraass BA, Lichter AS, McShan DL, et al. The influence of lung density corrections on treatment planning for primary breast cancer. Int J Radiat Oncol Biol Phys 1988 14: 179 90.
7. Solin LJ, Chu JC, Sontag MR, et al. Three-dimensional photon treatment planning of the intact breast. Int J Radiat Oncol Biol Phys 1991 21: 193 203.
8. Van Dyk J, Keane TJ, Rider WD. Lung density as measured by computerized tomography: implications for radiotherapy. Int J Radiat Oncol Biol Phys 1982 8: 1363 72.
9. Rosenblum LJ, Mauceri RA, Wellenstein DE, et al. Density patterns in the normal lung as determined by computed tomography. Radiology 1980 137: 409 16.
10. Pierce LJ, Strawderman MH, Douglas KR, Lichter AS. Conservative surgery and radiotherapy for early-stage breast cancer using a lung density correction: the University of Michigan experience. Int J Radiat Oncol Biol Phys 1997 39: 921 28.
11. Pierce LJ, Griffith KA, Hayman JA, Douglas KR, Lichter AS. Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results. Int J Radiat Oncol Biol Phys 2005 61: 1317 27.
12. Harris JR, Levene MB, Svensson G, Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 1979 5: 257 61.
13. Olivotto IA, Rose MA, Osteen RT, et al. Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys 1989 17: 747 53.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958 53: 457 81.
15. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999 18: 695 706.
16. Pepe M. Inference for events with dependent risks in multiple endpoint studies. JASA 1991 86: 770 78.
17. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999 353: 1993 2000.
18. http://ctep.cancer.gov/forms/CTCAEv3.pdf. Accessed April 1, 2006.
19. Rodrigues N, Carter D, Dillon D, Parisot N, Choi DH, Haffty BG. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2002 54: 1331 35.
20. Nakamura S, Woo C, Silberman H, Streeter OE, Lewinsky BS, Silverstein MJ. Breast-conserving therapy for ductal carcinoma in situ: a 20-year experience with excision plus radiation therapy. Am J Surg 2002 184: 403 9.
21. Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, et al. Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. Int J Radiat Oncol Biol Phys 2002 53: 868 79.
22. Vargas C, Kestin L, Go N, et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys 2005 63: 141 9.
23. Fraass BA, Roberson PL, Lichter AS. Dose to the contralateral breast due to primary breast irradiation. Int J Radiat Oncol Biol Phys 1985 11: 485 97.
24. Solin LJ, Fourquet A, Vicini FA, et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys 2001 50: 991 1002.
25. Solin LJ, Fourquet A, Vicini FA, et al. Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. Eur J Cancer 2005 41: 1715 23.
26. Kestin LL, Goldstein NS, Martinez AA, et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results. Ann Surg 2000 231: 235 45.
27. Vicini FA, Kestin LL, Goldstein NS, et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Clin Oncol 2000 18: 296 306.
28. Solin LJ, Fourquet A, Vicini FA, et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 2005 103: 1137 46.
29. Goldstein NS, Vicini FA, Kestin LL, Thomas M. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age. Cancer 2000 88: 2553 60.
30. Rodrigues NA, Dillon D, Carter D, Parisot N, Haffty BG. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women. Cancer 2003 97: 1393 403.
31. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001 19: 2263 71.
32. Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI. Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999. Cancer 2000 88: 946 54.
33. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999 340: 1455 61.
34. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999 86: 429 38.
35. Consensus. Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee. Cancer 1997 80: 1798 802.
36. White J, Levine A, Gustafson G, et al. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995 31: 791 97.
37. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Radiation after lumpectomy for DCIS to reduce the risk of invasive breast cancer: A population-based study. 2005 ASCO Annual Meeting Proceeding J Clin Oncol 2005 23 (June 1 Suppl 516.
38. Fowble B, Hanlon AL, Fein DA, et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys 1997 38: 949 57.
39. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003 56: 1038 45.
40. Taylor ME, Perez CA, Halverson KJ, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995 31: 753 64.
41. Wazer DE, DiPetrillo T, Schmidt-Ullrich R, et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1992 10: 356 63.